☆DIADEMA PARTNERS LP
Quality Q
0.064
AUM ($M)
283
Positions
78
Turnover
0.42
Top-10 wt
62%
Herfindahl
0.049
History (qtrs)
6
Excess Return
—
AI Eval Run AI Eval
Holdings · 115 positions · portfolio value $283M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆UTHR funds › | UNITED THERAPEUTICS CORP DEL | ADD | — | 10.1% | +3.5% | 28.7 | 52,989 | +25,686 | 2 | — |
| ☆RVMD funds › | REVOLUTION MEDICINES INC | ADD | — | 9.2% | +6.0% | 26.1 | 139,218 | +58,346 | 2 | — |
| ☆ABVX funds › | ABIVAX SA | ADD | — | 7.6% | +4.2% | 21.6 | 163,644 | +87,700 | 2 | — |
| ☆COGT funds › | COGENT BIOSCIENCES INC | ADD | — | 6.7% | +1.6% | 19.1 | 493,664 | +170,900 | 2 | — |
| ☆CUSIP:10806XAJ1 funds › | BRIDGEBIO PHARMA INC | HOLD | — | 6.6% | -1.1% | 18.6 | 250,000 | +0 | 2 | — |
| ☆BMRN funds › | BIOMARIN PHARMACEUTICAL INC | ADD | — | 6.3% | +2.9% | 17.9 | 312,846 | +164,617 | 2 | — |
| ☆VKTX funds › | VIKING THERAPEUTICS INC | TRIM | — | 6.1% | -1.0% | 17.2 | 441,808 | -83,373 | 2 | — |
| ☆EWTX funds › | EDGEWISE THERAPEUTICS INC | NEW | — | 3.9% | +3.9% | 11.1 | 272,214 | +272,214 | 1 | — |
| ☆KOD funds › | KODIAK SCIENCES INC | ADD | — | 3.0% | -0.0% | 8.5 | 218,117 | +25,155 | 2 | — |
| ☆IMCR funds › | IMMUNOCORE HLDGS PLC | ADD | — | 2.9% | +0.5% | 8.1 | 254,863 | +61,674 | 2 | — |
| ☆FDMT funds › | 4D MOLECULAR THERAPEUTICS IN | NEW | — | 2.7% | +2.7% | 7.6 | 571,107 | +571,107 | 1 | — |
| ☆RCUS funds › | ARCUS BIOSCIENCES INC | TRIM | — | 2.4% | +0.3% | 6.9 | 223,810 | -14,332 | 2 | — |
| ☆JNJ funds › | JOHNSON & JOHNSON | TRIM | — | 2.0% | -3.5% | 5.6 | 22,000 | -31,771 | 2 | — |
| ☆NVO funds › | NOVO-NORDISK A S | ADD | — | 1.7% | +1.5% | 4.8 | 100,000 | +85,423 | 2 | — |
| ☆CRVS funds › | CORVUS PHARMACEUTICALS INC | ADD | — | 1.6% | +0.1% | 4.4 | 294,811 | +50,000 | 2 | — |
| ☆RLAY funds › | RELAY THERAPEUTICS INC | NEW | — | 1.5% | +1.5% | 4.3 | 230,677 | +230,677 | 1 | — |
| ☆ZYME funds › | ZYMEWORKS INC | HOLD | — | 1.3% | -0.2% | 3.7 | 142,132 | +0 | 2 | — |
| ☆BIOA funds › | BIOAGE LABS INC | ADD | — | 1.3% | +0.8% | 3.6 | 146,334 | +86,334 | 2 | — |
| ☆TSHA funds › | TAYSHA GENE THERAPIES INC | NEW | — | 1.3% | +1.3% | 3.6 | 522,619 | +522,619 | 1 | — |
| ☆NRIX funds › | NURIX THERAPEUTICS INC | NEW | — | 1.0% | +1.0% | 2.9 | 121,539 | +121,539 | 1 | — |
| ☆CRBP funds › | CORBUS PHARMACEUTICALS HLDGS | TRIM | — | 1.0% | -0.7% | 2.8 | 301,264 | -138,693 | 2 | — |
| ☆INDV funds › | INDIVIOR PHARMACEUTICALS INC | TRIM | — | 1.0% | +0.1% | 2.8 | 67,512 | -3,864 | 2 | — |
| ☆IVA funds › | INVENTIVA SA | ADD | — | 1.0% | +0.2% | 2.7 | 740,786 | +388,387 | 2 | — |
| ☆ORKA funds › | ORUKA THERAPEUTICS INC | NEW | — | 0.9% | +0.9% | 2.6 | 27,799 | +27,799 | 1 | — |
| ☆PCVX funds › | VAXCYTE INC | ADD | — | 0.9% | +0.3% | 2.6 | 45,071 | +20,000 | 2 | — |
| ☆RLMD funds › | RELMADA THERAPEUTICS INC | ADD | — | 0.9% | +0.3% | 2.5 | 361,367 | +160,525 | 2 | — |
| ☆VERA funds › | VERA THERAPEUTICS INC | NEW | — | 0.9% | +0.9% | 2.5 | 57,608 | +57,608 | 1 | — |
| ☆CTNM funds › | CONTINEUM THERAPEUTICS INC | NEW | — | 0.7% | +0.7% | 2.0 | 119,733 | +119,733 | 1 | — |
| ☆BCYC funds › | BICYCLE THERAPEUTICS PLC | TRIM | — | 0.7% | -0.2% | 2.0 | 462,724 | -13,700 | 2 | — |
| ☆GLUE funds › | MONTE ROSA THERAPEUTICS INC | TRIM | — | 0.7% | -0.6% | 1.9 | 78,391 | -108,916 | 2 | — |
| ☆VRDN funds › | VIRIDIAN THERAPEUTICS INC | NEW | — | 0.6% | +0.6% | 1.8 | 100,000 | +100,000 | 1 | — |
| ☆MGNX funds › | MACROGENICS INC | TRIM | — | 0.6% | -0.1% | 1.7 | 374,403 | -225,597 | 2 | — |
| ☆PRQR funds › | PROQR THRAPEUTICS N V | ADD | — | 0.6% | +0.5% | 1.7 | 926,016 | +745,933 | 2 | — |
| ☆SPRB funds › | SPRUCE BIOSCIENCES INC | ADD | — | 0.6% | +0.3% | 1.6 | 30,000 | +20,000 | 2 | — |
| ☆ARDX funds › | ARDELYX INC | NEW | — | 0.5% | +0.5% | 1.5 | 303,025 | +303,025 | 1 | — |
| ☆CUE funds › | CUE BIOPHARMA INC | NEW | — | 0.5% | +0.5% | 1.5 | 48,369 | +48,369 | 1 | — |
| ☆MLYS funds › | MINERALYS THERAPEUTICS INC | ADD | — | 0.5% | +0.2% | 1.5 | 56,347 | +30,000 | 2 | — |
| ☆PRTA funds › | PROTHENA CORP PLC | NEW | — | 0.5% | +0.5% | 1.5 | 149,482 | +149,482 | 1 | — |
| ☆VYGR funds › | VOYAGER THERAPEUTICS INC | TRIM | — | 0.5% | -0.2% | 1.4 | 413,642 | -10,000 | 2 | — |
| ☆UNCY funds › | UNICYCIVE THERAPEUTICS INC | ADD | — | 0.5% | +0.2% | 1.4 | 303,676 | +197,593 | 2 | — |
| ☆PHAT funds › | PHATHOM PHARMACEUTICALS INC | ADD | — | 0.5% | +0.2% | 1.4 | 129,950 | +75,300 | 2 | — |
| ☆SYRE funds › | SPYRE THERAPEUTICS INC | NEW | — | 0.5% | +0.5% | 1.3 | 15,000 | +15,000 | 1 | — |
| ☆HELP funds › | CYBIN INC | NEW | — | 0.5% | +0.5% | 1.3 | 200,000 | +200,000 | 1 | — |
| ☆EQ funds › | EQUILLIUM INC | TRIM | — | 0.5% | +0.1% | 1.3 | 400,282 | -33,562 | 2 | — |
| ☆XERS funds › | XERIS BIOPHARMA HOLDINGS INC | HOLD | — | 0.4% | +0.1% | 1.1 | 132,746 | +0 | 2 | — |
| ☆PHVS funds › | PHARVARIS N V | HOLD | — | 0.4% | +0.0% | 1.0 | 29,321 | +0 | 2 | — |
| ☆HRMY funds › | HARMONY BIOSCIENCES HLDGS IN | TRIM | — | 0.3% | -0.7% | 1.0 | 26,864 | -66,000 | 2 | — |
| ☆RNAC funds › | CARTESIAN THERAPEUTICS INC | NEW | — | 0.3% | +0.3% | 0.9 | 87,057 | +87,057 | 1 | — |
| ☆RIGL funds › | RIGEL PHARMACEUTICALS INC | NEW | — | 0.3% | +0.3% | 0.9 | 22,816 | +22,816 | 1 | — |
| ☆SMMT funds › | SUMMIT THERAPEUTICS INC | NEW | — | 0.3% | +0.3% | 0.9 | 60,000 | +60,000 | 1 | — |
| ☆PGEN funds › | PRECIGEN INC | ADD | — | 0.3% | +0.2% | 0.8 | 135,293 | +80,000 | 2 | — |
| ☆DFTX funds › | DEFINIUM THERAPEUTICS INC | NEW | — | 0.3% | +0.3% | 0.7 | 15,451 | +15,451 | 1 | — |
| ☆PTHS funds › | PELTHOS THERAPEUTICS INC | HOLD | — | 0.2% | +0.0% | 0.7 | 24,773 | +0 | 2 | — |
| ☆PEPG funds › | PEPGEN INC | ADD | — | 0.2% | +0.1% | 0.7 | 373,284 | +222,359 | 2 | — |
| ☆ELVN funds › | ENLIVEN THERAPEUTICS INC | ADD | — | 0.2% | +0.2% | 0.5 | 10,000 | +9,755 | 2 | — |
| ☆CNTB funds › | CONNECT BIOPHARMA HLDGS LTD | TRIM | — | 0.2% | -0.1% | 0.5 | 196,985 | -3,705 | 2 | — |
| ☆LRMR funds › | LARIMAR THERAPEUTICS INC | TRIM | — | 0.2% | -0.2% | 0.4 | 146,637 | -20,000 | 2 | — |
| ☆CLRB funds › | CELLECTAR BIOSCIENCES INC | NEW | — | 0.1% | +0.1% | 0.4 | 138,341 | +138,341 | 1 | — |
| ☆FHTX funds › | FOGHORN THERAPEUTICS INC | TRIM | — | 0.1% | -0.0% | 0.3 | 66,908 | -13,036 | 2 | — |
| ☆AYTU funds › | AYTU BIOPHARMA INC | TRIM | — | 0.1% | -0.3% | 0.3 | 148,546 | -204,531 | 2 | — |
| ☆OCGN funds › | OCUGEN INC | HOLD | — | 0.1% | -0.0% | 0.3 | 200,000 | +0 | 2 | — |
| ☆URGN funds › | UROGEN PHARMA LTD | TRIM | — | 0.1% | -0.1% | 0.3 | 7,137 | -16,018 | 2 | — |
| ☆AMGN funds › | AMGEN INC | NEW | — | 0.1% | +0.1% | 0.2 | 102,701 | +102,701 | 1 | — |
| ☆HRTX funds › | HERON THERAPEUTICS INC | NEW | — | 0.1% | +0.1% | 0.2 | 458,723 | +458,723 | 1 | — |
| ☆TLPH funds › | TALPHERA INC | HOLD | — | 0.1% | +0.0% | 0.2 | 153,563 | +0 | 2 | — |
| ☆ANNX funds › | ANNEXON INC | TRIM | — | 0.1% | -0.2% | 0.2 | 27,516 | -105,400 | 2 | — |
| ☆MNPR funds › | MONOPAR THERAPEUTICS INC | HOLD | — | 0.1% | +0.0% | 0.2 | 1,630 | +0 | 2 | — |
| ☆LAKE funds › | LAKELAND INDS INC | NEW | — | 0.1% | +0.1% | 0.2 | 14,108 | +14,108 | 1 | — |
| ☆UPB funds › | UPSTREAM BIO INC | TRIM | — | 0.0% | -0.0% | 0.1 | 19,093 | -2,516 | 2 | — |
| ☆MGTX funds › | MEIRAGTX HLDGS PLC | NEW | — | 0.0% | +0.0% | 0.1 | 8,368 | +8,368 | 1 | — |
| ☆JATT funds › | JATT II ACQUISITION CORP | NEW | — | 0.0% | +0.0% | 0.1 | 9,021 | +9,021 | 1 | — |
| ☆KLRA funds › | KAILERA THERAPEUTICS INC | NEW | — | 0.0% | +0.0% | 0.1 | 3,621 | +3,621 | 1 | — |
| ☆MNKD funds › | MANNKIND CORP | TRIM | — | 0.0% | -0.2% | 0.1 | 16,003 | -170,600 | 2 | — |
| ☆ENTX funds › | ENTERA BIO LTD | HOLD | — | 0.0% | +0.0% | 0.0 | 23,260 | +0 | 2 | — |
| ☆SPRY funds › | ARS PHARMACEUTICALS INC | NEW | — | 0.0% | +0.0% | 0.0 | 4,860 | +4,860 | 1 | — |
| ☆APRE funds › | APREA THERAPEUTICS INC | NEW | — | 0.0% | +0.0% | 0.0 | 44,907 | +44,907 | 1 | — |
| ☆TVRD funds › | TVARDI THERAPEUTICS INC | NEW | — | 0.0% | +0.0% | 0.0 | 16,607 | +16,607 | 1 | — |
| ☆NXTC funds › | NEXTCURE INC | NEW | — | 0.0% | +0.0% | 0.0 | 7,742 | +7,742 | 1 | — |
| ☆VRTX funds › | VERTEX PHARMACEUTICALS INC | EXIT | — | 0.0% | -0.7% | 0.0 | 0 | -3,840 | 0 | — |
| ☆CUSIP:22978P106 funds › | CUE BIOPHARMA INC | EXIT | — | 0.0% | -0.0% | 0.0 | 0 | -131,997 | 0 | — |
| ☆TRVI funds › | TREVI THERAPEUTICS INC | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -21,663 | 0 | — |
| ☆GPCR funds › | STRUCTURE THERAPEUTICS INC | EXIT | — | 0.0% | -1.4% | 0.0 | 0 | -72,234 | 0 | — |
| ☆CAPR funds › | CAPRICOR THERAPEUTICS INC | EXIT | — | 0.0% | -1.0% | 0.0 | 0 | -78,851 | 0 | — |
| ☆CMPS funds › | COMPASS PATHWAYS PLC | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -31,885 | 0 | — |
| ☆TGTX funds › | TG THERAPEUTICS INC | EXIT | — | 0.0% | -2.8% | 0.0 | 0 | -206,928 | 0 | — |
| ☆RCKT funds › | ROCKET PHARMACEUTICALS INC | EXIT | — | 0.0% | -0.0% | 0.0 | 0 | -30,579 | 0 | — |
| ☆QURE funds › | UNIQURE NV | EXIT | — | 0.0% | -0.2% | 0.0 | 0 | -31,200 | 0 | — |
| ☆LLY funds › | ELI LILLY & CO | EXIT | — | 0.0% | -2.3% | 0.0 | 0 | -6,000 | 0 | — |
| ☆REPL funds › | REPLIMUNE GROUP INC | EXIT | — | 0.0% | -0.3% | 0.0 | 0 | -100,660 | 0 | — |
| ☆EYPT funds › | EYEPOINT INC | EXIT | — | 0.0% | -1.0% | 0.0 | 0 | -178,545 | 0 | — |
| ☆CELC funds › | CELCUITY INC | EXIT | — | 0.0% | -0.3% | 0.0 | 0 | -5,314 | 0 | — |
| ☆EPRX funds › | EUPRAXIA PHARMACEUTICALS INC | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -40,000 | 0 | — |
| ☆RARE funds › | ULTRAGENYX PHARMACEUTICAL IN | EXIT | — | 0.0% | -0.3% | 0.0 | 0 | -35,144 | 0 | — |
| ☆TARS funds › | TARSUS PHARMACEUTICALS INC | EXIT | — | 0.0% | -0.8% | 0.0 | 0 | -25,942 | 0 | — |
| ☆PRTCY funds › | PURETECH HEALTH PLC | EXIT | — | 0.0% | -0.0% | 0.0 | 0 | -7,924 | 0 | — |
| ☆MAZE funds › | MAZE THERAPEUTICS INC | EXIT | — | 0.0% | -0.2% | 0.0 | 0 | -15,000 | 0 | — |
| ☆PASG funds › | PASSAGE BIO INC | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -19,530 | 0 | — |
| ☆TENX funds › | TENAX THERAPEUTICS INC | EXIT | — | 0.0% | -1.2% | 0.0 | 0 | -179,738 | 0 | — |
| ☆CLYM funds › | CLIMB BIO INC | EXIT | — | 0.0% | -0.8% | 0.0 | 0 | -286,126 | 0 | — |
| ☆RNA funds › | ATRIUM THERAPEUTICS INC | EXIT | — | 0.0% | -0.0% | 0.0 | 0 | -2,512 | 0 | — |
| ☆ENTA funds › | ENANTA PHARMACEUTICALS INC | EXIT | — | 0.0% | -0.3% | 0.0 | 0 | -64,952 | 0 | — |
| ☆SEPN funds › | SEPTERNA INC | EXIT | — | 0.0% | -0.0% | 0.0 | 0 | -202 | 0 | — |
| ☆STTK funds › | SHATTUCK LABS INC | EXIT | — | 0.0% | -0.8% | 0.0 | 0 | -293,664 | 0 | — |
| ☆CUSIP:880881107 funds › | TERNS PHARMACEUTICALS INC | EXIT | — | 0.0% | -4.0% | 0.0 | 0 | -181,752 | 0 | — |
| ☆CORT funds › | CORCEPT THERAPEUTICS INC | EXIT | — | 0.0% | -0.2% | 0.0 | 0 | -10,000 | 0 | — |
| ☆GHRS funds › | GH RESEARCH PLC | EXIT | — | 0.0% | -0.2% | 0.0 | 0 | -26,836 | 0 | — |
| ☆INO funds › | INOVIO PHARMACEUTICALS INC | EXIT | — | 0.0% | -0.4% | 0.0 | 0 | -562,665 | 0 | — |
| ☆ABBV funds › | ABBVIE INC | EXIT | — | 0.0% | -2.2% | 0.0 | 0 | -24,058 | 0 | — |
| ☆VTGN funds › | VISTAGEN THERAPEUTICS INC | EXIT | — | 0.0% | -0.0% | 0.0 | 0 | -105,428 | 0 | — |
| ☆BBIO funds › | BRIDGEBIO PHARMA INC | EXIT | — | 0.0% | -2.6% | 0.0 | 0 | -85,311 | 0 | — |
| ☆CUSIP:53630X203 funds › | LIPOCINE INC NEW | EXIT | — | 0.0% | -0.2% | 0.0 | 0 | -50,000 | 0 | — |
| ☆JAZZ funds › | JAZZ PHARMACEUTICALS PLC | EXIT | — | 0.0% | -4.3% | 0.0 | 0 | -54,755 | 0 | — |
| ☆INCY funds › | INCYTE CORP | EXIT | — | 0.0% | -3.0% | 0.0 | 0 | -78,029 | 0 | — |
| ☆ALKS funds › | ALKERMES PLC | EXIT | — | 0.0% | -0.7% | 0.0 | 0 | -50,000 | 0 | — |
| ☆DNTH funds › | DIANTHUS THERAPEUTICS INC | EXIT | — | 0.0% | -0.3% | 0.0 | 0 | -10,000 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 283 | 78 | 0.42 | 62% | 0.049 | 0.065 | — | in |
| 2026Q1 | 242 | 86 | 0.51 | 50% | 0.035 | 0.020 | — | entered |
| 2025Q4 | 168 | 73 | 0.64 | 51% | 0.037 | 0.000 | — | left |
| 2025Q3 | 144 | 59 | 0.55 | 56% | 0.046 | 0.010 | — | in |
| 2025Q2 | 161 | 46 | 0.45 | 70% | 0.064 | 0.053 | — | entered |
| 2025Q1 | 125 | 43 | 0.00 | 68% | 0.067 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status